 |
 |
|
|
|  PubMed
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 November 2002 | Volume 137 Issue 9 | Pages 744-752
Background: Acute tubular necrosis (ATN) is common in hospitalized patients, particularly in the intensive care unit. Over the past four decades, the mortality rate from ATN has remained at 50% to 80%.
Purpose: To review recent studies of diagnosis and treatment strategies for ATN.
Data Sources: MEDLINE search for all clinical studies of therapies for ATN, supplemented by a review of the references of the identified articles.
Study Selection: Prospective studies and major retrospective studies evaluating therapies for ATN.
Data Extraction: Data on the study sample, interventions performed, results, side effects, and duration of follow-up.
Data Synthesis: Early diagnosis of ATN by exclusion of prerenal and postrenal causes of acute renal failure, examination of urinary sediment, and analysis of urine measures (for example, fractional excretion of sodium in the absence of diuretics) can allow the early involvement of nephrologists and improve survival. Enteral rather than parenteral hyperalimentation in severely malnourished patients may improve survival. Sepsis causes 30% to 70% of deaths in patients with ATN; therefore, avoidance of intravenous lines, bladder catheters, and respirators is recommended. Because septic patients are vasodilated, large volumes of administered fluid accumulate in the lung interstitium of these patients. This condition necessitates ventilatory support, which when prolonged leads to acute respiratory distress syndrome, multiorgan failure, and increased mortality. More aggressive dialysis (for example, given daily) with biocompatible membranes may improve survival in some patients with acute renal failure.
Conclusions: New information about the importance of early diagnosis and supportive care for patients with ATN has emerged. However, randomized trials of these interventions are needed to test their effect on the morbidity and mortality of ATN.
Author and Article Information
From University of Colorado Health Sciences Center, Denver, Colorado.
Grant Support: By National Institutes of Health grants DK52599 and DK07135.
Requests for Single Reprints: Robert W. Schrier, MD, University of Colorado Health Sciences Center, Box B178, 4200 East 9th Avenue, Denver, CO 80262; e-mail, robert.schrier{at}uchsc.edu.
Current Author Addresses: Drs. Esson and Schrier: University of Colorado Health Sciences Center, Box B178, 4200 East 9th Avenue, Denver, CO 80262. REVIEW
Diagnosis and Treatment of Acute Tubular Necrosis
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. A. Perazella and C. R. Parikh How Can Urine Microscopy Influence the Differential Diagnosis of AKI? Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 691 - 693. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ponte, C. Felipe, A. Muriel, M. T. Tenorio, and F. Liano Long-term functional evolution after an acute kidney injury: a 10-year study Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3859 - 3866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Perazella, S. G. Coca, M. Kanbay, U. C. Brewster, and C. R. Parikh Diagnostic Value of Urine Microscopy for Differential Diagnosis of Acute Kidney Injury in Hospitalized Patients Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1615 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Villanueva, C. Cespedes, A. A. Gonzalez, E. Roessler, and C. P. Vio Inhibition of bFGF-receptor type 2 increases kidney damage and suppresses nephrogenic protein expression after ischemic acute renal failure Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R819 - R828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Korrapati, J. Chilakapati, F. A. Witzmann, C. Rao, E. A. Lock, and H. M. Mehendale Proteomics of S-(1, 2-dichlorovinyl)-L-cysteine-induced acute renal failure and autoprotection in mice Am J Physiol Renal Physiol, October 1, 2007; 293(4): F994 - F1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Cruz, I. Bolgan, M. A. Perazella, M. Bonello, M. de Cal, V. Corradi, N. Polanco, C. Ocampo, F. Nalesso, P. Piccinni, et al. North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): Targeting the Problem with the RIFLE Criteria Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 418 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Villanueva, C. Cespedes, A. A. Gonzalez, C. P. Vio, and V. Velarde Effect of ischemic acute renal damage on the expression of COX-2 and oxidative stress-related elements in rat kidney Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1364 - F1371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Jo, M. H. Rosner, and M. D. Okusa Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven't Worked and What Is on the Horizon Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 356 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Villanueva, C. Cespedes, A. Gonzalez, and C. P. Vio bFGF induces an earlier expression of nephrogenic proteins after ischemic acute renal failure Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1677 - R1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Villanueva, C. Cespedes, and C. P. Vio Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R861 - R870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Biju, Y. Akai, N. Shrimanker, and V. H. Haase Protection of HIF-1-deficient primary renal tubular epithelial cells from hypoxia-induced cell death is glucose dependent Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1217 - F1226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gai, V. Cantaluppi, C. Fenocchio, D. Motta, S. Masini, A. Pacitti, and G. Lanfranco Presence of Protein Fragments in Urine of Critically Ill Patients with Acute Renal Failure: A Nephrologic Enigma Clin. Chem., October 1, 2004; 50(10): 1822 - 1824. [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Schrier and W. Wang Acute Renal Failure and Sepsis N. Engl. J. Med., July 8, 2004; 351(2): 159 - 169. [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Parikh, B. M. Sandmaier, R. F. Storb, K. G. Blume, F. Sahebi, D. G. Maloney, M. B. Maris, Y. Nieto, C. L. Edelstein, R. W. Schrier, et al. Acute Renal Failure after Nonmyeloablative Hematopoietic Cell Transplantation J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1868 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Herget-Rosenthal, D. Poppen, J. Husing, G. Marggraf, F. Pietruck, H.-G. Jakob, T. Philipp, and A. Kribben Prognostic Value of Tubular Proteinuria and Enzymuria in Nonoliguric Acute Tubular Necrosis Clin. Chem., March 1, 2004; 50(3): 552 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Stefanec Management of Acute Renal Failure Ann Intern Med, September 16, 2003; 139(6): 530 - 530. [Full Text] [PDF]
|
|
|
|
|
|
W. L. Jackson Jr. Management of Acute Renal Failure Ann Intern Med, September 16, 2003; 139(6): 529 - 530. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Finucane Management of Acute Renal Failure Ann Intern Med, September 16, 2003; 139(6): 530 - 530. [Full Text] [PDF]
|
|
